Insider sells 134,609 CVX shares; option exercise also reported (CVX)

Rhea-AI Filing Summary

R HEWITT PATE reported insider transactions including an exercise of stock options and multiple 10b5-1 sales of Common stock.

The filing lists an exercise of stock options resulting in 47,200 shares issued on 03/06/2026 for cash, and 10b5-1 open-market sales on 01/30/2026 (41,134 shares, $7,256,037.60), 02/27/2026 (35,475 shares, $6,600,563.64), and 03/02/2026 (58,000 shares, $10,941,850.80).

Insights

Corporate Governance Expert

Routine insider exercise and scheduled 10b5-1 sales were reported, showing planned disposition activity.

The filing documents an exercise of stock options for 47,200 shares on 03/06/2026 and three scheduled 10b5-1 sales totaling 134,609 shares across 01/30/2026, 02/27/2026, and 03/02/2026 with aggregate proceeds shown.

These entries reflect reported disposition and option-exercise mechanics; timing and sale method (10b5-1) are disclosed, and cash-flow recipients are shown as proceeds amounts. Subsequent filings may disclose additional transactions or clarifying footnotes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47200	8963280.00	1995385539	03/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2026	Exercise of Stock Options	Issuer			47200	03/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for R HEWITT PATE 1400 Smith Street Houston TX 77002	Common	03/02/2026	58000	10941850.80
10b5-1 Sales for R HEWITT PATE 1400 Smith Street Houston TX 77002	Common	02/27/2026	35475	6600563.64
10b5-1 Sales for R HEWITT PATE 1400 Smith Street Houston TX 77002	Common	01/30/2026	41134	7256037.60

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Form 144 for CVX disclose about R Hewitt Pate's activity?

The Form 144 disclosed an option exercise of 47,200 shares on 03/06/2026 and three 10b5-1 sales totaling 134,609 shares. The filing lists cash proceeds for each sale: $7,256,037.60, $6,600,563.64, and $10,941,850.80.

How many shares were sold under 10b5-1 plans in the CVX Form 144?

The filing shows three 10b5-1 sale transactions totaling 134,609 shares: 41,134 shares on 01/30/2026, 35,475 shares on 02/27/2026, and 58,000 shares on 03/02/2026.

What proceeds were reported for the 10b5-1 sales in the CVX filing?

The reported proceeds are $7,256,037.60 for 41,134 shares (01/30/2026), $6,600,563.64 for 35,475 shares (02/27/2026), and $10,941,850.80 for 58,000 shares (03/02/2026).

Was an option exercise included in the CVX Form 144 and what was its size?

Yes. The Form 144 records an exercise of stock options for 47,200 shares on 03/06/2026, with the method of payment indicated as cash in the filing.

Do the CVX filings indicate the sales were market trades or private transactions?

The sales are labeled as 10b5-1 plan sales, which are prearranged open-market dispositions; the filing lists dates, share counts, and cash proceeds but does not add further execution detail beyond the 10b5-1 designation.